Oncología Traslacional
ONCTRAS
Stanford University School of Medicine
Stanford, Estados UnidosPublicacións en colaboración con investigadores/as de Stanford University School of Medicine (3)
2019
2015
-
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer
Current Medical Research and Opinion, Vol. 31, Núm. 6, pp. 1129-1137